News
Novel genetic therapy reduces key protein in Huntington’s disease
- Author:
- Jennie Smith
Intrathecal therapy was associated with dose-dependent reductions in mutant huntingtin protein, but clinical change will require further study.
News
Polyglutamine diseases are rare, but not the mutations that cause them
- Author:
- Jennie Smith
A population-based study found more than 10% of European adults carried CAG repeats in the pathogenic range, despite lacking signs of disease.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/mycobacterium_avium_web.jpg)
Non-TB mycobacteria infections rising in COPD patients
- Author:
- Jennie Smith
A study using VA patient data found a sharp uptick in non-TB mycobacteria infections from 2012 and a higher risk of death.
News
Perioperative M&M similar for lobar, sublobar surgeries in early lung cancer
- Author:
- Jennie Smith
Though disease-free survival results are still pending, mortality and adverse effects were similar at 30 and 90 days.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/November-2018/135771_photo8_web.jpg)
Huntington’s research returns to Latin America, as scientists tread with care
- Author:
- Jennie Smith
Poor people in Latin America contributed to some of the biggest discoveries in Huntington’s disease research. Scientists want to work with them...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/Primary_CNS_lymphoma_Image-by-Nephron.jpg)
New PCNSL guidelines emphasize importance of patient fitness
- Author:
- Jennie Smith
New guidelines on the diagnosis and management of patients with primary central nervous system lymphoma (PCNSL) emphasize prompt diagnosis,...
News
CNS lymphoma guidelines stress patient fitness, not age, in choosing treatment
- Author:
- Jennie Smith
Patients should be diagnosed fast, treated as aggressively as organ health permits, and in clinical trials if possible.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/pregnant_woman_abdomen_web.jpg)
RFM awareness program not effective at preventing stillbirths
- Author:
- Jennie Smith
Asking women to report reduced fetal movements only led to more C-sections and inductions.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/August-2018/Marie_Paraiso_web.jpg)
FDA warning shines light on vaginal rejuvenation
- Author:
- Jennie Smith
Lasers and radio-frequency machines are being marketed for unapproved vaginal indications, the agency says – with burns and other adverse effects...
News
Oral drug seen preventing angioedema attacks
- Author:
- Jennie Smith
A novel agent led to a nearly 75% reduction in monthly attacks among people with a rare genetic disorder.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/July-2018/Wolfe_Frederick_KS_web.jpg)
Fibromyalgia should be seen as one, not two disorders
- Author:
- Jennie Smith
Symptom burden is the same whether fibromyalgia is primary or secondary.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/May-2018/woman_older_depressed_web.jpg)
Transient epileptic amnesia: Rare, treatable, and easy to miss
- Author:
- Jennie Smith
LOS ANGELES – A review of cases finds that neuroimaging with FDG-PET reveals focal abnormalities
News
Peripheral nerve stimulation can reduce tremor symptoms
- Author:
- Jennie Smith
LOS ANGELES - A wrist device delivers transient relief following a 40-minute stimulation session.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/April-2018/headache2_web.jpg)
Cluster headache presents differently in never-smokers, survey finds
- Author:
- Jennie Smith
LOS ANGELES – Patients not exposed to tobacco developed cluster headache at a younger age than exposed subjects.
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/April-2018/richard_lipton.jpg)
VIDEO: Eptinezumab shows efficacy in episodic and chronic migraine trials
- Author:
- Jennie Smith
LOS ANGELES – One-third of patients on a high dose of the novel CGRP-blocking monoclonal antibody saw migraines reduced by 75%.